Gene Editing for Agtech picks up pace

Caribou Biosciences, a startup founded by Jennifer Doudna, the scientist largely attributed with the discovery of the CRISPR-Cas9 gene editing tool, has raised $30 million in Series B funding. Dutch food and agriculture technology venture firm Anterra Capitalinvested alongside fellow agtech-focused VC Pontifax AgTech, healthcare investor Heritage Group, and Maverick Capital Ventures out of Dallas, Texas. Existing investors F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures also joined the round. Anterra Capital’s Philip Austin will join Caribou’s board. Caribou is developing the gene editing technology for use across agriculture, therapeutics, biological research,

Is Now the Time to Invest in Ag Tech?

A look at a market that some GPs claim is overlooked by private equity, which means greater opportunity for those already investing. Despite the growing global population and demand for food, agriculture is still an under-represented sector in private equity, but several specialist firms are pursuing agricultural technology as a source of outsized returns. The thesis: ag tech will be the primary means to sustainably increase food production to meet the ever-growing demand. Privcap spoke to two PE players actively providing growth capital to the ag tech sector—New York-based Paine & Partners and California- and Israel-based Pontifax Global Food and Agriculture Technology Fund—about opportunit

Recent Posts
Archive

2025 S Westgate Ave, First Floor, Los Angeles, CA 90025

info@pontifaxagtech.com  |  323-306-9970 

© 2014 Pontifax Global Food and Agriculture Technology Fund LP

  • LinkedIn Social Icon